Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Orgenesis
Orgenesis
Activities:
Research & Development
Pharmaceutical
Cell & Gene Therapy
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Regulatory
Orgenesis and Theracell collaboration designated priority investment in Greece
As a result of this designation, the venture will be inducted into the country’s fast-track licensing and approval process
Research & Development
Orgenesis announces collaboration with Tel Aviv Medical Center
The collaboration aims to advance point-of-care development and commercialisation of cell and gene and therapies
Finance
Orgenesis to collaborate with Savicell on ImmunoBiopsy platform
The collaboration aims to develop and validate diagnostic kits for enhanced quality control (QC) and monitoring purposes to be used by Orgenesis for CGT applications
Research & Development
Orgenesis to trial Tissue Genesis Icellator tech for cell recovery
The trial is supported by the National Stem Cell Foundation and an OREF clinical research grant in cellular therapy in honour of James Urbaniak, MD
Drug Delivery
Orgenesis signs joint venture with Cure Therapeutics
The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies
Pharmaceutical
Orgenesis launches cell-based vaccine platform targeting SARS-CoV-2
US biotech has created a cell-based vaccine platform targeting solid tumours for use against viral diseases
Finance
Orgenesis acquires cell therapy manufacturer MaSTherCell
Acquisition to accelerate type 1 diabetes therapeutic into clinical trials and diversify future business model and product offering
Subscribe now